FineMark National Bank & Trust’s Orthofix Medical OFIX Stock Holding History

FineMark National Bank & Trust’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,148	Closed	-$463K	–	390
2018 Q2	$463K	Buy	8,148 +1,292	+19%	+$73.6K	0.03%	264
2018 Q1	$403K	Buy	6,856 +1,991	+41%	+$112K	0.03%	267
2017 Q4	$266K	Buy	+4,865	New	+$252K	0.02%	314

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FineMark National Bank & Trust's OFIX Position: Q3 2018 in Review

FineMark National Bank & Trust sold out of Orthofix Medical (OFIX) in Q3 2018, closing a stake of 8,148 shares — an estimated $463K sold.

FineMark National Bank & Trust first reported a position in OFIX in Q4 2017 and held it in 3 quarters. The position peaked at $463K in Q2 2018. 162 funds tracked by Wall St. Rank hold OFIX as of Q3 2018.

FineMark National Bank & Trust reported no remaining Orthofix Medical position as of Q3 2018 after selling out during the quarter.
FineMark National Bank & Trust sold 8,148 Orthofix Medical shares in Q3 2018, an estimated $463K.
FineMark National Bank & Trust first reported a position in Orthofix Medical in Q4 2017 and held it in 3 quarters.
FineMark National Bank & Trust's Orthofix Medical position peaked at $463K in Q2 2018.
162 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2018.

Based on FineMark National Bank & Trust's 13F filing for Q3 2018, filed 2 Nov 2018.